US2007160661A1PendingUtilityA1

Aspirin formulation for cardiovascular health

Assignee: FINKELSTEIN DAVIDPriority: Dec 30, 2005Filed: Mar 19, 2007Published: Jul 12, 2007
Est. expiryDec 30, 2025(expired)· nominal 20-yr term from priority
A61K 31/195A61K 31/44A61K 31/60A61K 31/70A61K 31/495
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates generally to an aspirin formulation which may comprise additional vitamins, minerals, herbs and supplements and methods for using the same for maintaining cardiovascular health. The aspirin formulation may comprise supplements such as vitamin B6, vitamin B12, folic acid, arginine and garlic. The invention also encompasses methods for maintaining healthy blood pressure and cholesterol levels with the aspirin formulation described herein.

Claims

exact text as granted — not AI-modified
1 . A formulation comprising aspirin, vitamin B6, vitamin B12, folic acid, arginine and garlic.  
   
   
       2 . The formulation of  claim 1 , wherein the aspirin is a low dose of aspirin, wherein the low dose aspirin is a daily aspirin dose less than about 200 mg.  
   
   
       3 . The formulation of  claim 1 , wherein the folic acid is folate.  
   
   
       4 . The formulation of  claim 1 , wherein the arginine is L-arginine.  
   
   
       5 . A caplet or tablet comprising the formulation of  claim 1 .  
   
   
       6 . The caplet or tablet of  claim 5 , wherein a dosage per caplet or tablet of aspirin is 81 mg, vitamin B6 is 25 mg, vitamin B12 is 200 mcg, folic acid is 600 mcg, arginine is 200 mg and garlic is 500 mg.  
   
   
       7 . The caplet or tablet of  claim 5  further comprising cellulose, silica and magnesium stearate.  
   
   
       8 . The caplet or tablet of  claim 5  further comprising calcium carbonate, carnauba wax, colloidal silicon dioxide, crospovidone, hypromellulose, lactose, magnesium stearate, maltodextrin, microcrystalline cellulose, pregelatinized starch, sodium starch, glycolate, stearic acid, titanium dioxide, tracetin, zinc stearate or any combination thereof.  
   
   
       9 . The caplet or tablet of  claim 5  wherein the caplet or tablet does not contain gluten, preservatives, sugar, sodium, milk, yeast, artificial colors, artificial flavors or any combination thereof.  
   
   
       10 . The caplet or tablet of  claim 5  wherein the caplet or tablet is enteric coated.  
   
   
       11 . A method of maintaining healthy blood pressure and cholesterol levels comprising administering the caplet or tablet of  claim 5  to a patient in need of maintenance of healthy blood pressure and cholesterol levels.  
   
   
       12 . The method of  claim 11  wherein the caplet or tablet is administered once per day.

Join the waitlist — get patent alerts

Track US2007160661A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.